Cue Biopharma files 1-for-30 reverse stock split to maintain Nasdaq listing

Cue Biopharma, Inc.

1-for-30 reverse stock split effective 5:00 PM ET on April 23, 2026; no fractional shares, cash in lieu.
Common stock begins trading post-split on April 24 under symbol CUE; new CUSIP 22978P205.
Reverse split aims to meet Nasdaq minimum bid price requirement, as disclosed in proxy statement.
No change in authorized shares ($0.001 par); options and warrants proportionately adjusted.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.